Dizal (jiangsu) Pharmaceutical Co., Ltd.

This study tests a new drug combination (DZD8586 plus other medicines) in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma who have not yet been treated. The goal is to see if the combination can control the cancer for at least 2 years and to check for side …

This study tests a new drug called DZD8586 against standard treatments in about 250 adults whose chronic lymphocytic leukemia or small lymphocytic lymphoma has come back or stopped responding to prior therapy. The goal is to see if DZD8586 can keep the cancer from growing longer …

This study tests a daily pill called sunvozertinib against a placebo in 360 people with a specific type of lung cancer (stage IB-IIIA non-small cell) that has certain gene changes (EGFR exon20ins or PACC). All participants have had their tumor completely removed by surgery. The g…

This study tests a new combination of two drugs, DZD6008 and sunvozertinib, in adults with advanced non-small cell lung cancer that has specific EGFR mutations. The goal is to see if the combination is safe and can shrink or control tumors. About 200 participants will take part i…